BSW
NAUT icon

Buckingham Strategic Wealth’s Nautilus Biotechnolgy NAUT Stock Holding History

Buckingham Strategic Wealth’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,711
Closed -$41.5K – 703
2023
Q2 		$41.5K Hold
10,711
– – ﹤0.01% 681
2023
Q1 		$19.3K Hold
10,711
– – ﹤0.01% 613
2022
Q4 		$19.3K Buy
+10,711
New +$20.7K ﹤0.01% 615

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return
AEPLI
AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return

Buckingham Strategic Wealth's NAUT Position: Q3 2023 in Review

Buckingham Strategic Wealth sold out of Nautilus Biotechnolgy (NAUT) in Q3 2023, closing a stake of 10,711 shares — an estimated $41.5K sold.

Buckingham Strategic Wealth first reported a position in NAUT in Q4 2022 and held it in 3 quarters. The position peaked at $41.5K in Q2 2023. 75 funds tracked by Wall St. Rank hold NAUT as of Q3 2023.

  • Buckingham Strategic Wealth reported no remaining Nautilus Biotechnolgy position as of Q3 2023 after selling out during the quarter.
  • Buckingham Strategic Wealth sold 10,711 Nautilus Biotechnolgy shares in Q3 2023, an estimated $41.5K.
  • Buckingham Strategic Wealth first reported a position in Nautilus Biotechnolgy in Q4 2022 and held it in 3 quarters.
  • Buckingham Strategic Wealth's Nautilus Biotechnolgy position peaked at $41.5K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2023.

Based on Buckingham Strategic Wealth's 13F filing for Q3 2023, filed 13 Nov 2023.